Latest News and Press Releases
Want to stay updated on the latest news?
-
CytoSorbents to Report Q2 2024 Financial and Operating Results
-
CytoSorbents regains compliance with Nasdaq minimum bid price requirement
-
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
-
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
-
CytoSorbents CEO Dr. Phillip Chan to highlight its innovative critical care and cardiac surgery blood purification therapy at AAPI Conference this weekend
-
$20 million credit facility provides CytoSorbents with important non-dilutive capital to support its regulatory and commercialization objectives
-
新澤西州，普林斯頓, June 26, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO) 是透過其專屬的聚合物吸附技術使用血液淨化在深切治療部和心臟手術治療致命病症的領導者，現宣布CytoSorb®在台灣獲得食品藥物管理署 (TFDA)...
-
Taiwan FDA approval of CytoSorb brings powerful blood purification therapy to critically ill and cardiac surgery patients in the country
-
The launch of the PuriFi hemoperfusion machine is expected to increase the demand and sales of CytoSorbents’ leading CytoSorb® blood purification therapy
-
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting